The present invention relates to a composition comprising a) recombinant exosporium-producing Bacillus cells that express a fusion protein comprising: (i) at least one plant growth stimulating protein or peptide and (ii) a targeting sequence that localizes the fusion protein to the exosporium of the Bacillus cells; and b) at least one particular insecticide disclosed herein in a synergistically effective amount. Furthermore, the present invention relates to the use of this composition as well as a method for enhancing plant growth, promoting plant health, and/or reducing overall damage of plants and plant parts.

The present invention relates to a composition comprising a) recombinant exosporium-producing Bacillus cells that express a fusion protein comprising: (i) at least one plant growth stimulating protein or peptide and (ii) a targeting sequence that localizes the fusion protein to the exosporium of the Bacillus cells; and b) at least one particular insecticide disclosed herein in a synergistically effective amount. Furthermore, the present invention relates to the use of this composition as well as a method for enhancing plant growth, promoting plant health, and/or reducing overall damage of plants and plant parts.

The present invention relates to a composition comprising a) recombinant exosporium-producing Bacillus cells that express a fusion protein comprising: (i) at least one plant growth stimulating protein or peptide and (ii) a targeting sequence that localizes the fusion protein to the exosporium of the Bacillus cells; and b) at least one particular insecticide disclosed herein in a synergistically effective amount. Furthermore, the present invention relates to the use of this composition as well as a method for enhancing plant growth, promoting plant health, and/or reducing overall damage of plants and plant parts.

A biocide testing system includes test columns, a bypass tube, control valves, and a control system. Each test column includes biocide test coupons. The bypass tube is fluidly coupled to each of the test columns. Each control valve is coupled between a respective test column and the bypass tube. The control system performs operations including: controlling the control valves to fluidly couple the test columns to a water source; controlling a pump to circulate water from the water source into the test columns to immerse each test coupon in water; controlling the control valves to fluidly isolate the test columns from the water source and to fluidly isolate each test column from the other test columns; controlling a particular control valve to fluidly couple a particular test column to a biocide source; and controlling the pump to circulate biocide from the biocide source into the particular test column to immerse the test coupons in the particular test column in biocide.

A biocide testing system includes test columns, a bypass tube, control valves, and a control system. Each test column includes biocide test coupons. The bypass tube is fluidly coupled to each of the test columns. Each control valve is coupled between a respective test column and the bypass tube. The control system performs operations including: controlling the control valves to fluidly couple the test columns to a water source; controlling a pump to circulate water from the water source into the test columns to immerse each test coupon in water; controlling the control valves to fluidly isolate the test columns from the water source and to fluidly isolate each test column from the other test columns; controlling a particular control valve to fluidly couple a particular test column to a biocide source; and controlling the pump to circulate biocide from the biocide source into the particular test column to immerse the test coupons in the particular test column in biocide.

The present invention provides new pharmaceutical and vaccine compositions comprising Treponema spp. bacterins, supplemented with antigens from Treponema spp. or other digital dermatitis causative pathological agents such as but not limited to D. nodosus or F. necrophorum, for effectively immunizing susceptible mammals, preferably ungulates, against DD, in particular against bovine digital dermatitis. The present invention also identifies Treponema pedis and Treponema phagedenis as two of the etiologic agents of digital dermatitis (DD) in mammals, in particular ungulate digital dermatitis. The invention therefore also provides isolated cultures of Treponema pedis and Treponema phagedenis for effectively immunizing susceptible mammals, preferably ungulates, against DD, in particular against bovine digital dermatitis. In addition, the present invention provides methods of diagnosing DD by detecting infection with a series of specific Treponema antigens.

The present disclosure includes methods and components for production of valuable industrial compounds in yeast. In an embodiment, the present invention provides a nucleic acid construct with increased stability for gene expression or gene editing comprising: a nucleic acid sequence encoding one or more of SEQ ID NO: 1-8 (CENs 1-8); and one or more regulatory elements functional in a yeast cell. In an embodiment of the present invention the nucleic acid constructs are vectors, preferably episomal vectors. High expression promoters, as well as methods for increasing production of compounds such as aromatics are disclosed.

Disclosed herein are therapeutic compositions containing non-pathogenic, germination-competent bacterial spores, for the prevention, control, and treatment of gastrointestinal diseases, disorders and conditions and for general nutritional health.

The present invention provides a combination containing (1) a composition containing a live bacterium of Bacteroides vulgatus isolated from nature, and (2) a composition containing a live bacterium of Bacteroides dorei isolated from nature.

Provided are compositions and methods for selectively reducing the amount of antibiotic resistant and/or virulent bacteria in a mixed bacteria population, or for reducing any other type of unwanted bacteria in a mixed bacteria population. The compositions and methods involve targeting bacteria that are differentiated from other members of the population by at least one unique clustered regularly interspaced short palindromic repeats (CRISPR) targeted DNA sequence. The compositions and methods can be readily adapted to target any bacteria or any bacteria plasmid, or both.